Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

38 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
High ΔNp73/TAp73 ratio is associated with poor prognosis in acute promyelocytic leukemia.
Lucena-Araujo AR, Kim HT, Thomé C, Jacomo RH, Melo RA, Bittencourt R, Pasquini R, Pagnano K, Glória AB, Chauffaille Mde L, Athayde M, Chiattone CS, Mito I, Bendlin R, Souza C, Bortolheiro C, Coelho-Silva JL, Schrier SL, Tallman MS, Grimwade D, Ganser A, Berliner N, Ribeiro RC, Lo-Coco F, Löwenberg B, Sanz MA, Rego EM. Lucena-Araujo AR, et al. Blood. 2015 Nov 12;126(20):2302-6. doi: 10.1182/blood-2015-01-623330. Epub 2015 Oct 1. Blood. 2015. PMID: 26429976 Free PMC article. Clinical Trial.
Prognostic importance of CD56 expression in intermediate risk acute myeloid leukaemia.
Coelho-Silva JL, Carvalho LE, Oliveira MM, Franca-Neto PL, Andrade AT, Lima AS, Bezerra MF, Lima MM, Neves MA, Fonseca JM, Barros-Correia MC, Machado CG, Bezerra MA, Matos DM, Lucena-Araujo AR. Coelho-Silva JL, et al. Br J Haematol. 2017 Feb;176(3):498-501. doi: 10.1111/bjh.13971. Epub 2016 Feb 23. Br J Haematol. 2017. PMID: 26914377 Free article. No abstract available.
ΔNp73 overexpression promotes resistance to apoptosis but does not cooperate with PML/RARA in the induction of an APL-leukemic phenotype.
Lucena-Araujo AR, Coelho-Silva JL, Pereira-Martins DA, Thomé C, Scheucher PS, Lange AP, Paiva HH, Hemmelgarn BT, Morais-Sobral MC, Azevedo EA, Franca-Neto PL, Franca RF, Silva CL, Krause A, Rego EM. Lucena-Araujo AR, et al. Oncotarget. 2017 Jan 31;8(5):8475-8483. doi: 10.18632/oncotarget.14295. Oncotarget. 2017. PMID: 28035072 Free PMC article.
Interleukin-6 G-174C polymorphism predicts higher risk of stroke in sickle cell anaemia.
Domingos IF, Pereira-Martins DA, Coelho-Silva JL, Borges-Medeiros RL, Falcão DA, Azevedo RC, Anjos AC, Costa FF, Mendonça TF, Cavalcanti MS, Araujo AS, Lucena-Araujo AR, Bezerra MA. Domingos IF, et al. Br J Haematol. 2018 Jul;182(2):294-297. doi: 10.1111/bjh.14773. Epub 2017 May 23. Br J Haematol. 2018. PMID: 28542795 Free article. No abstract available.
Clinical impact of BAALC expression in high-risk acute promyelocytic leukemia.
Lucena-Araujo AR, Pereira-Martins DA, Koury LC, Franca-Neto PL, Coelho-Silva JL, de Deus Wagatsuma VM, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Chiattone CS, Fagundes EM, Chauffaille ML, Schrier SL, Tallman MS, Ribeiro RC, Grimwade D, Ganser A, Löwenberg B, Lo-Coco F, Sanz MA, Berliner N, Rego EM. Lucena-Araujo AR, et al. Blood Adv. 2017 Sep 15;1(21):1807-1814. doi: 10.1182/bloodadvances.2017005926. eCollection 2017 Sep 26. Blood Adv. 2017. PMID: 29296827 Free PMC article.
Combining gene mutation with gene expression analysis improves outcome prediction in acute promyelocytic leukemia.
Lucena-Araujo AR, Coelho-Silva JL, Pereira-Martins DA, Silveira DR, Koury LC, Melo RAM, Bittencourt R, Pagnano K, Pasquini R, Nunes EC, Fagundes EM, Gloria AB, Kerbauy F, de Lourdes Chauffaille M, Bendit I, Rocha V, Keating A, Tallman MS, Ribeiro RC, Dillon R, Ganser A, Löwenberg B, Valk PJM, Lo-Coco F, Sanz MA, Berliner N, Rego EM. Lucena-Araujo AR, et al. Blood. 2019 Sep 19;134(12):951-959. doi: 10.1182/blood.2019000239. Epub 2019 Jul 10. Blood. 2019. PMID: 31292112 Free PMC article.
38 results